EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity

Ilse R Kelters iD, Markella I Printezi iD, Annabelle Ballesta, Pieterjan Dierickx iD, Yvonne Koop iD, Pasquale F Innominato, Francis A Lévi, J Corné van Dam, Pieter A Doevendans iD, Alwin D R Huitema, Arco J Teske iD, Anne M May und 2 weitere

Cardiovascular Research · 22.11.2025 · 121 (14) · 2144-2156

DOI: 10.1093/cvr/cvaf179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 06.10.2025. Verfasst von Ilse R Kelters und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Experimental Cardiology Laboratory, Division of Heart & Lungs, University Medical Center Utrecht, Heidelberglaan 100, 35…. Hauptthemen laut MEDLINE: Anthracyclines, Circadian Rhythm, Heart Diseases, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Heart Foundation, Alliance Fund, ZonMw Psider-Heart.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracycline cardiotoxicity is a severe chemotherapeutic side effect that can lead to heart failure in cancer patients and survivors. Chronomodulated chemotherapy is a promising preventive strategy that encompasses the adjustment of anthracycline administration time to the circadian rhythms (24-hour rhythms) of the body. Circadian rhythms play a major role in cardiovascular physiology and disease and may lead to a time-dependent variation in cardiac sensitivity to anthracyclines. In this review, all available evidence on the topic of chronomodulated anthracyclines for cardiotoxicity reduction and/or oncological efficacy enhancement is summarized. In total, 3 in vitro studies, 12 animal studies, and 9 clinical studies were included. Potential mechanistic explanations involved 24-hour variation in oxidative stress regulation, DNA damage repair, and systemic or intracellular pharmacokinetics. We identified a hypothesized optimal time frame from 3 to 11 AM for anthracycline administration in humans, based on extrapolation of findings in animal studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesCircadian RhythmHeart DiseasesAntibiotics, AntineoplasticDrug ChronotherapyHumansAnimalsCardiotoxicityTime FactorsRisk FactorsTreatment OutcomeOxidative StressDrug Administration Schedule

Stichwörter der Autor:innen

AnthracyclineCardio-oncologyCardiotoxicityChronomodulationChronotherapyCircadian Rhythms

Substanzen

AnthracyclinesAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Cardiology and Experimental Cardiology Laboratory, Division of Heart & Lungs, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
  • Inserm Unit 900, Cancer Systems Pharmacology Team, Institut Curie, Saint-Cloud, France.
  • Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
  • Cardiopulmonary Institute (CPI), Bad Nauheim, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Bad Nauheim, Germany.
  • Julius Center for Health Sciences and Primary Care, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.

ORCID-Profile: Ilse R Kelters, Markella I Printezi, Pieterjan Dierickx, Yvonne Koop, Pieter A Doevendans, Arco J Teske, Linda W van Laake

Förderung

  • Dutch Heart Foundation
  • Alliance Fund
  • ZonMw Psider-Heart
  • NOW-TTP HARVEY
  • PLN Foundation
  • Health Cardinnov
  • European Research Council
  • Horizon 2020 programme

Zitieren

APA

Kelters, I. R., Printezi, M. I., Ballesta, A., Dierickx, P., Koop, Y., Innominato, P. F., Lévi, F. A., van Dam, J. C., Doevendans, P. A., Huitema, A. D. R., Teske, A. J., May, A. M., Sluijter, J. P. G., & van Laake, L. W. (2025). Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity. Cardiovascular Research, 121(14), 2144-2156. https://doi.org/10.1093/cvr/cvaf179

Vancouver

Kelters IR, Printezi MI, Ballesta A, Dierickx P, Koop Y, Innominato PF, et al. Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity. Cardiovascular Research. 2025;121(14):2144-2156. doi:10.1093/cvr/cvaf179

BibTeX
@article{Kelters2025,
  author = {Kelters, Ilse R and Printezi, Markella I and Ballesta, Annabelle and Dierickx, Pieterjan and Koop, Yvonne and Innominato, Pasquale F and Lévi, Francis A and van Dam, J Corné and Doevendans, Pieter A and Huitema, Alwin D R and Teske, Arco J and May, Anne M and Sluijter, Joost P G and van Laake, Linda W},
  title = {Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {14},
  pages = {2144--2156},
  doi = {10.1093/cvr/cvaf179}
}
Kostenlos starten →